Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XK-related X-linked protein (XKRX)
- Target
- XKRX
- Molecular classification
- Membrane transporter (putative), Multi-pass transmembrane protein, Kell blood group complex family (blood group antigen protein family), Not a GPCR, ion channel, enzyme, receptor, or transcription factor per current knowledge
01
Overview
The XK-related X-linked protein (XKRX) is a putative membrane transporter expressed in various tissues, including red blood cells, brain, muscle, and heart. It is closely related to the XK protein, a critical component of the XK/Kell blood group antigen system, implicated in maintaining the structural integrity of red blood cells. Deficiency or mutation results in McLeod syndrome, which includes hemolytic anemia, neuromuscular and neurological symptoms, and acanthocytosis. Though structurally similar to transporters, the exact cellular transport function of XKRX remains unclear, and it is not currently targeted by approved drugs. XKRX serves as a biomarker for blood group antigen characterization and is relevant for patient selection in transfusion medicine. Genetic testing for variants in XKRX is key in diagnosing McLeod syndrome and other related disorders.
- Other names
- XK-related X-linkedXKRXXK, Kell blood group complex subunit-related, X-linkedX Kell blood group precursor-related, X-linkedX-linked Kx blood group related, X-linked
02
Mechanism of action
Not established; no direct drug mechanisms reported. Pathology arises mainly from genetic absence or mutation, disrupting RBC membrane function and antigen profile.
03
Biological functions
Maintenance of red blood cell membrane integrityPotential role in transport of substances into/out of cells (putative transporter)Exposure at cell surface involved in blood group antigen presentation (Kx antigen)Formation of XK/Kell complex
04
Disease associations
McLeod syndrome (neuroacanthocytosis, hemolytic anemia, neuromuscular, and neurological defects)Possible involvement (by association) in Huntington Disease-Like 2 (rare)Other: RBC disorders related to Kell/Kx antigen
05
Safety considerations
For transfusion: mismatched Kx antigen can trigger immune reaction (hemolytic transfusion reactions)For patients: implications are mainly from inherited deficiency (disease risk, not a pharmacological safety issue)Not a target for classical safety concern in drug development
06
Biomarkers
Kx antigen (for blood group matching, transfusion safety)XK protein (for molecular/gene testing, e.g., McLeod syndrome diagnosis)Abnormal RBC morphology (acanthocytosis in McLeod syndrome)Kell/XK complex abnormality
Beyond the preview
Go deeper on XK-related X-linked protein (XKRX).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XK-related X-linked protein (XKRX).